Akash Marathakam

474 total citations
19 papers, 381 citations indexed

About

Akash Marathakam is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Akash Marathakam has authored 19 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Akash Marathakam's work include Natural Antidiabetic Agents Studies (4 papers), Synthesis and biological activity (3 papers) and Analytical Chemistry and Chromatography (3 papers). Akash Marathakam is often cited by papers focused on Natural Antidiabetic Agents Studies (4 papers), Synthesis and biological activity (3 papers) and Analytical Chemistry and Chromatography (3 papers). Akash Marathakam collaborates with scholars based in India, Bangladesh and Mexico. Akash Marathakam's co-authors include Bijo Mathew, Md. Sahab Uddin, Githa Elizabeth Mathew, Della Grace Thomas Parambi, M.K. Unnikrishnan, Jobin Jose, Simone Carradori, Hoon Kim, Vishnu Sankar Sivasankarapillai and Monu Joy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Journal of Molecular Liquids.

In The Last Decade

Akash Marathakam

18 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akash Marathakam India 10 126 121 97 61 57 19 381
Giuliana Ottonello Italy 15 95 0.8× 233 1.9× 97 1.0× 62 1.0× 22 0.4× 24 522
Jong‐Hyun Park South Korea 15 161 1.3× 291 2.4× 228 2.4× 62 1.0× 68 1.2× 39 752
Maricarmen Hernández‐Rodríguez Mexico 13 117 0.9× 194 1.6× 92 0.9× 134 2.2× 92 1.6× 31 480
Baichen Xiong China 9 233 1.8× 144 1.2× 89 0.9× 157 2.6× 68 1.2× 13 450
Qihang Li China 12 229 1.8× 157 1.3× 104 1.1× 159 2.6× 65 1.1× 29 448
Hee Kim South Korea 12 168 1.3× 176 1.5× 119 1.2× 100 1.6× 249 4.4× 26 680
Judit Müller Hungary 12 45 0.4× 118 1.0× 74 0.8× 38 0.6× 31 0.5× 19 365
Catia Cornacchia Italy 14 100 0.8× 233 1.9× 125 1.3× 33 0.5× 75 1.3× 17 576
Waralee Ruankham Thailand 11 62 0.5× 233 1.9× 73 0.8× 21 0.3× 75 1.3× 30 508
Shuaishuai Xing China 13 242 1.9× 259 2.1× 154 1.6× 163 2.7× 74 1.3× 22 689

Countries citing papers authored by Akash Marathakam

Since Specialization
Citations

This map shows the geographic impact of Akash Marathakam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akash Marathakam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akash Marathakam more than expected).

Fields of papers citing papers by Akash Marathakam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akash Marathakam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akash Marathakam. The network helps show where Akash Marathakam may publish in the future.

Co-authorship network of co-authors of Akash Marathakam

This figure shows the co-authorship network connecting the top 25 collaborators of Akash Marathakam. A scholar is included among the top collaborators of Akash Marathakam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akash Marathakam. Akash Marathakam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Haque, M. Akiful, Akash Marathakam, Samar J. Almehmadi, et al.. (2023). Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors. Molecules. 28(2). 501–501. 9 indexed citations
2.
Marathakam, Akash, et al.. (2022). insight of development and validation of bioanalytical method in the reference of anticancer drugs by using LC-MS/MS. International Journal of Health Sciences. 6349–6361. 6 indexed citations
3.
Marathakam, Akash, et al.. (2022). A Review on Antiviral Activity of Favipiravir. Journal of Pharmaceutical Research International. 1–7. 3 indexed citations
4.
Marathakam, Akash, et al.. (2022). Fedratinib: A Review of Its Pharmacology and Clinical Use. Journal of Pharmaceutical Research International. 51–58.
6.
Marathakam, Akash, et al.. (2021). Stability Indicating Method Development and Validation of Cenobamate in Bulk and Dosage form by Liquid Chromatography. Journal of Pharmaceutical Research International. 120–131. 2 indexed citations
7.
Harilal, Seetha, Jobin Jose, Della Grace Thomas Parambi, et al.. (2020). Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules. Brain Research Bulletin. 160. 121–140. 89 indexed citations
8.
Marathakam, Akash, et al.. (2020). Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease. Current Protein and Peptide Science. 21(12). 1164–1173. 8 indexed citations
9.
Kumar, Rajesh, Seetha Harilal, Della Grace Thomas Parambi, et al.. (2020). Fascinating Chemopreventive Story of Wogonin: A Chance to Hit on the Head in Cancer Treatment. Current Pharmaceutical Design. 27(4). 467–478. 12 indexed citations
10.
Sivasankarapillai, Vishnu Sankar, et al.. (2019). Silicon Quantum Dots: Promising Theranostic Probes for the Future. Current Drug Targets. 20(12). 1255–1263. 32 indexed citations
11.
Unnikrishnan, M.K., et al.. (2019). Fifty Years of Oral Rehydration Therapy:Forgotten Contributions from the Indian Subcontinent. Current Science. 117(5). 884–887. 1 indexed citations
12.
Mathew, Bijo, Della Grace Thomas Parambi, Vishnu Sankar Sivasankarapillai, et al.. (2019). Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review. CNS & Neurological Disorders - Drug Targets. 18(6). 432–445. 48 indexed citations
13.
Mathew, Bijo, Della Grace Thomas Parambi, Githa Elizabeth Mathew, et al.. (2019). Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. Archiv der Pharmazie. 352(11). e1900177–e1900177. 117 indexed citations
14.
Chaves, Otávio Augusto, Bijo Mathew, Della Grace Thomas Parambi, et al.. (2019). Studies on the interaction between HSA and new halogenated metformin derivatives: influence of lipophilic groups in the binding ability. Journal of Biomolecular Structure and Dynamics. 38(7). 2128–2140. 10 indexed citations
15.
Chaves, Otávio Augusto, et al.. (2018). Introduction of fluorinated environment on metformin. Evaluation of its serum-albumin interaction with molecular modeling studies. Journal of Molecular Liquids. 260. 186–194. 10 indexed citations
16.
Sreelatha, Harikrishnan Vijayakumar, et al.. (2017). Gelucire: An Optional Innovative Tool for both Sustained and Fast Release of Drugs in Treating Diabetes Mellitus Type II Disease. Asian Journal of Research in Pharmaceutical Sciences. 7(1). 33–33. 2 indexed citations
18.
Kannappan, N., et al.. (2013). In vitro xanthine oxidase inhibitory and antioxidant activities of aerial parts of Flacourtia sepiaria Roxb. Oriental Pharmacy and Experimental Medicine. 13(2). 113–120. 4 indexed citations
19.
Marathakam, Akash, et al.. (2012). Studies on phytochemical and In-Vitro antioxidant potential of Justicia beddomei (Clarke) Bennett. Free Radicals and Antioxidants. 2(4). 26–31. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026